Paul Tudor Jones's BSX Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 660,186 shares of Boston Scientific Corporation (BSX) worth $64.45 M, representing 0.11% of the portfolio. First purchased in 2013-Q3, this long-term strategic position has been held for 39 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in BSX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2015, adding 629,446 shares. Largest reduction occurred in Q3 2015, reducing 650,000 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2013 | +13,100 | New Buy | 13,100 | $11.76 |
| Q4 2013 | -13,100 | Sold Out | 0 | $0.00 |
| Q1 2014 | +17,944 | New Buy | 17,944 | $13.54 |
| Q2 2014 | +9,096 | Add 50.69% | 27,040 | $12.76 |
| Q3 2014 | +62,301 | Add 230.40% | 89,341 | $11.81 |
| Q4 2014 | +73,160 | Add 81.89% | 162,501 | $13.25 |
| Q1 2015 | -141,947 | Reduce 87.35% | 20,554 | $17.76 |
| Q2 2015 | +629,446 | Add 3062.40% | 650,000 | $17.70 |
| Q3 2015 | -650,000 | Sold Out | 0 | $0.00 |
| Q2 2016 | +33,994 | New Buy | 33,994 | $23.36 |
| Q3 2016 | -7,384 | Reduce 21.72% | 26,610 | $23.79 |
| Q4 2016 | -26,610 | Sold Out | 0 | $0.00 |
| Q4 2017 | +195,667 | New Buy | 195,667 | $24.79 |
| Q1 2018 | -168,980 | Reduce 86.36% | 26,687 | $27.32 |
| Q2 2018 | +3,936 | Add 14.75% | 30,623 | $32.69 |
| Q3 2018 | -30,623 | Sold Out | 0 | $0.00 |
| Q1 2019 | +61,225 | New Buy | 61,225 | $38.38 |
| Q2 2019 | -61,225 | Sold Out | 0 | $0.00 |
| Q1 2020 | +46,362 | New Buy | 46,362 | $32.63 |
| Q2 2020 | -13,462 | Reduce 29.04% | 32,900 | $35.11 |
| Q3 2020 | +48,401 | Add 147.12% | 81,301 | $38.22 |
| Q4 2020 | -69,180 | Reduce 85.09% | 12,121 | $35.97 |
| Q1 2021 | +9,103 | Add 75.10% | 21,224 | $38.64 |
| Q2 2021 | -21,224 | Sold Out | 0 | $0.00 |
| Q3 2021 | +10,200 | New Buy | 10,200 | $43.43 |
| Q4 2021 | +6,556 | Add 64.27% | 16,756 | $42.49 |
| Q1 2022 | +11,417 | Add 68.14% | 28,173 | $44.30 |
| Q2 2022 | -28,173 | Sold Out | 0 | $0.00 |
| Q1 2023 | +218,602 | New Buy | 218,602 | $0.05 |
| Q2 2023 | +17,634 | Add 8.07% | 236,236 | $54.09 |
| Q3 2023 | +72,449 | Add 30.67% | 308,685 | $52.80 |
| Q4 2023 | -104,697 | Reduce 33.92% | 203,988 | $57.81 |
| Q1 2024 | -47,279 | Reduce 23.18% | 156,709 | $68.49 |
| Q2 2024 | -142,175 | Reduce 90.73% | 14,534 | $77.01 |
| Q3 2024 | +315,270 | Add 2169.19% | 329,804 | $83.80 |
| Q4 2024 | -329,804 | Sold Out | 0 | $0.00 |
| Q1 2025 | +256,131 | New Buy | 256,131 | $100.88 |
| Q2 2025 | +394,489 | Add 154.02% | 650,620 | $107.41 |
| Q3 2025 | +9,566 | Add 1.47% | 660,186 | $97.63 |
Paul Tudor Jones's Boston Scientific Corporation Investment FAQs
Paul Tudor Jones first purchased Boston Scientific Corporation (BSX) in Q3 2013, acquiring 13,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Boston Scientific Corporation (BSX) for 39 quarters since Q3 2013.
Paul Tudor Jones's largest addition to Boston Scientific Corporation (BSX) was in Q2 2015, adding 650,000 shares worth $11.5 M.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 660,186 shares of Boston Scientific Corporation (BSX), valued at approximately $64.45 M.
As of the Q3 2025 filing, Boston Scientific Corporation (BSX) represents approximately 0.11% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Boston Scientific Corporation (BSX) was 660,186 shares, as reported at the end of Q3 2025.